116052 ⎘
Transferases transferring phosphorus-containing groups (2.7); Protein-tyrosine kinases (2.7.10) Non-specific protein-tyrosine kinase (2.7.10.2), i.e. spleen tyrosine kinase
INTERFERING RNA FOR INHIBITING JAK1 GENE EXPRESSION AND USE THEREOF
#2ANTISENSE OLIGONUCLEOTIDE, COMPOSITIONS AND PHARMACEUTICAL FORMULATIONS THEREOF FOR EXON SKIPPING
#3REAGENT FOR MEASURING TYROSINE KINASE ACTIVITY, AND USE THEREOF
#4DELIVERY OF MULTI-CYTOKINE SIGNALS BY OVEREXPRESSION OF WILD-TYPE OR MUTANT SIGNAL TRANSDUCTION MOLECULES
#5COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
#6PROTEIN TYROSINE KINASE 7 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#7ENGINEERING CHEMICALLY INDUCIBLE SPLIT PROTEIN ACTUATORS (CISPA)
#8MODULATION OF EXTRACELLULAR KINASE ACTIVITY AND FUNCTION FOR TREATMENT OF PAIN AND NEURODEGENERATIVE/NEUROIMMUNE DISEASE
#9CO-DELIVERY OF INHIBITORY NUCLEIC ACIDS AND GENOME EDITORS FOR TUMOR THERAPY
#10APPLICATION OF MECHANICAL-FORCE SENSITIVE MACROPHAGE SUBSET IN PANCREATIC CANCER DIAGNOSIS OR PROGNOSIS EVALUATION
#11Double Stranded Oligonucleotide For Modulating JAK1 Expression
#12Antisense Oligonucleotide (ASO) Gene Inhibition and Treatment
#13PYK2-DERIVED PEPTIDES FOR INHIBITING INVADOPODIA-MEDIATED CANCER METASTASIS
#14ANTI-ROR1 CHIMERIC ANTIGEN RECEPTORS (CARS), CELLS EXPRESSING THE CARS AND RELATED METHODS
#15COMPOSITIONS AND METHODS FOR TREATING RIGHT VENTRICLE DYSFUNCTION
#16UNIVERSAL CHIMERIC ANTIGEN RECEPTOR T-CELL AND APPLICATION THEREOF
#17CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING MOLECULES FOR CONTROLLED AND SPECIFIC CAR T CELL ACTIVITY
#18INDUCIBLE SIGNALLING PROTEIN
#19Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors
#20LUNG TREATMENT COMPOSITIONS
#21LENTIVIRAL VECTORS FOR THERAPEUTIC EXPRESSION OF BTK IN HEMATOPOIETIC CELLS
#22IN VIVO LYMPHOVENOUS ANASTOMOSIS
#23BRK PEPTIDES AND METHODS OF USE
#24Cell
#25POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF
#26ENGINEERED T CELL RECEPTORS AND USES THEREOF
#27METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE
#28CHIMERIC INHIBITORY RECEPTOR
#29Bruton's Tyrosine Kinase as Anti-Cancer Drug Target
#30TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#31SURROGATE CO-RECEPTORS FOR T CELLS AND METHODS OF USE
#32CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY
#33REDIRECTED CELLS WITH MHC CHIMERIC RECEPTORS AND METHODS OF USE IN IMMUNOTHERAPY
#34VECTOR PRODUCTION IN SERUM FREE MEDIA
#35BRUTON'S TYROSINE KINASE HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
#36COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
#37ENGINEERED CELL DEATH-INDUCING ENZYMES AND METHODS OF USE
#38Methods, compositions, and uses of novel FYN kinase inhibitors
#39FGFR3 binding molecules
#40OPTIMIZED LENTIVIRAL VECTOR FOR XLA GENE THERAPY
#41Methods and pharmaceutical composition for the treatment of neurodegenerative disease
#42ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF
#43Inhibiting FAK-AKT interaction to inhibit metastasis
#44BIFIDOBACTERIUM LONGUM
#45Protein Kinase C-delta targeted therapy for treating radiation injury
#46Membrane span-kinase fusion protein and the uses thereof
#47Anti-TIE2 antibodies and uses thereof
#48INHIBITION OF HISTONE METHYLTRANSFERASE FOR CARDIAC REPROGRAMMING
#49Human serum albumin binding compounds and fusion proteins thereof
#50Methods for predicting kinase inhibitor resistance
#51Conjugates comprising RIPK2 inhibitors
#53Compositions and methods for detecting mutations in JAK2 nucleic acid
#54ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#55TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#56FGFR3 binding molecules
#57METHODS FOR IN VITRO PRODUCTION OF PLATELETS AND COMPOSITIONS AND USES THEREOF
#58Redirected cells with MHC chimeric receptors and methods of use in immunotherapy
#59Method for treatment or prevention of a cancer
#60Treatment of ocular neovascularization using anti-VEGF proteins
#61METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA
#62Methods to Accelerate Wound Healing in Diabetic Subjects
#63Bruton's tyrosine kinase as anti-cancer drug target
#64ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#65NOVEL NUCLEIC ACID MOLECULES WITH ANTITUMORAL ACTIVITY
#66ANTI-HIMF ANTIBODIES TO TREAT LUNG DISEASES
#67PKC delta inhibitors for use as therapeutics
#68Bruton's tyrosine kinase as anti-cancer drug target
#69Anti-TIE2 antibodies and uses thereof
#70Benzimidazole analogues and related methods
#71Compositions and methods for detecting mutations in JAK2 nucleic acid
#73PKC delta inhibitors for use as therapeutics
#74Methods for treating ischemia-reperfusion injury
#75MELK epitope peptides and vaccines containing the same
#76Human serum albumin binding compounds and fusion proteins thereof
#77Bruton's tyrosine kinase as anti-cancer drug target
#78Inhibition of histone methyltransferase for cardiac reprogramming
#79Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease
#80Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)
#81Methods of treatment of cancer using SRC-modulating peptides
#82Crystal Structure of a NEF/SdAb19 Complex and Uses Thereof
#83Binding molecules with antitumoral activity
#84Cyclic molecules as bruton's tyrosine kinase inhibitors
#85Membrane span-kinase fusion protein and the uses thereof
#86Treatment of ocular neovascularization using anti-VEGF proteins
#87Azaindoles useful as inhibitors of Janus kinases
#88Bruton's tyrosine kinase as anti-cancer drug target
#89Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases
#90Inhibition of activated cdc42-associated kinase 1
#91Bruton's tyrosine kinase as anti-cancer drug target
#92Azaindoles useful as inhibitors of janus kinases
#93COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES
#94Compositions and methods for detecting mutations in JAK2 nucleic acid
#95Methods and compositions for inhibiting the proliferation of cancer cells
#96MELK epitope peptides and vaccines containing the same
#97Molecular Determinants Associated With Prostate Cancer And Methods Of Use Thereof
#98Prostate cancer related gene STYK1
#99Azaindoles useful as inhibitors of Janus kinases
#100COMPOSITIONS AND METHODS FOR INHIBITING INDUCIBLE T CELL KINASE (ITK) AND TREATING ASTHMA AND BRONCHIAL INFLAMMATIONS
#101BRUTON'S TYROSINE KINASE AS ANTI-CANCER DRUG TARGET
#102Methods and Systems for Searching for Regulators of the Fer Protein and for Monitoring the Effects of the Fer Protein
#103Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases
#104Anti-HIMF antibodies to treat lung diseases
#105COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID
#106Diagnosis, prevention and treatment of cancer
#107Azaindoles useful as inhibitors of janus kinases
#108Spleen tyrosine kinase catalytic domain:crystal structure and binding pockets thereof
#109Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions
#110Methods and reagents for inhibiting cell proliferation
#111Marker for cancer
#112Diagnosis, prevention and treatment of cancer
#113siRNA libraries optimized for predetermined protein families